CorMedix, Inc. (CRMD)
11.47
-0.15
(-1.29%)
USD |
NASDAQ |
Dec 10, 16:00
11.50
+0.03
(+0.26%)
After-Hours: 20:00
CorMedix Research and Development Expense (TTM): 12.46M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Pfizer Inc. | 10.13B |
| ANI Pharmaceuticals, Inc. | 56.05M |
| Arcutis Biotherapeutics, Inc. | 71.08M |
| Alkermes Plc | 283.30M |
| Talphera, Inc. | 5.795M |